ResearcherWright State UniversityNo recent work listed

Anita Thyagarajan-Sahu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0009-0002-1967-418X; OpenAlex author ID A5074961015. Sources: OpenAlex.

Their work

Papers: 6 (first author 3, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2018: 1 paper · 2019: 2 papers · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper

Papers 6

KRAS Pathway-based Therapeutic Approaches in Pancreatic Cancer. First author DOI 10.2174/1389557523666221226095931 ↗
Exploiting the relevance of CA 19-9 in pancreatic cancer. First author DOI 10.20517/2394-4722.2020.70 ↗
Dietary Polyphenols in Cancer Chemoprevention: Implications in Pancreatic Cancer. Co-author DOI 10.3390/antiox9080651 ↗
Exploring Signaling Pathways and Pancreatic Cancer Treatment Approaches Using Genetic Models. First author DOI 10.2174/1389557519666190327163644 ↗
Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches. Co-author DOI 10.3390/cancers11111627 ↗
Gemcitabine Induces Microvesicle Particle Release in a Platelet-Activating Factor-Receptor-Dependent Manner via Modulation of the MAPK Pathway in Pancreatic Ca… Co-author DOI 10.3390/ijms20010032 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ravi P. Sahu · 6 shared papers, 2018–2023 · strength 1.02
Abdullah Althaiban · 1 shared paper, 2023 · strength 0.31
- Paper KRAS Pathway-based Therapeutic Approaches in Pancreatic Cancer. DOI 10.2174/1389557523666221226095931 ↗
Syaza Salleh · 1 shared paper, 2020 · strength 0.19
- Paper Exploiting the relevance of CA 19-9 in pancreatic cancer. DOI 10.20517/2394-4722.2020.70 ↗
S. T. Sheik Abdul Khader · 1 shared paper, 2019 · strength 0.16
- Paper Exploring Signaling Pathways and Pancreatic Cancer Treatment Approaches Using Genetic Models. DOI 10.2174/1389557519666190327163644 ↗
Catherine M.T. Sherwin · 1 shared paper, 2019 · strength 0.11
- Paper Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches. DOI 10.3390/cancers11111627 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.